Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | MAOA | P21397 | 3/20 | 0.50 |
| ▸ | MAOB | P27338 | 3/20 | 0.50 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.48 |
| ▸ | MAP2K2 | P36507 | 1/20 | 0.48 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.48 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.46 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.46 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.46 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | BCL2 | P10415 | 1/20 | 0.44 |
| ▸ | HTR2C | P28335 | 1/20 | 0.44 |
| ▸ | HTR6 | P50406 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7708311 | 0.93 | MAOA (0.48) | LMNASMN1; SMN2MAOAMAOBHAO1 | |
| SCHEMBL30832956 | 0.92 | LMNA (0.57) | LMNASMN1; SMN2HAO1MAP2K2MAP2K1 | |
| SCHEMBL761802 | 0.92 | LMNA (0.57) | LMNASMN1; SMN2HAO1MAP2K2MAP2K1 | |
| SCHEMBL8514752 | 0.89 | LMNA (0.47) | LMNASMN1; SMN2MAOAMAOBHAO1 | |
| SCHEMBL11300299 | 0.84 | ALDH1A1 (0.50) | LMNASMN1; SMN2MAOAMAOBHAO1 | |
| SCHEMBL12952450 | 0.84 | LMNA (0.47) | LMNASMN1; SMN2MAOAMAOBHAO1 | |
| SCHEMBL14176682 | 0.84 | CYP2A6 (0.60) | LMNASMN1; SMN2HAO1MAP2K2MAP2K1 | |
| SCHEMBL8563632 | 0.84 | CYP3A4 (0.61) | LMNASMN1; SMN2HAO1MAP2K2MAP2K1 | |
| SCHEMBL8561255 | 0.82 | MAP2K2 (0.47) | LMNASMN1; SMN2MAOAMAOBHAO1 | |
| SCHEMBL6403168 | 0.82 | SIRT2 (0.53) | SMN1; SMN2SIRT2SIRT1SIRT3KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111902738-A | Naphthyl-based high refractive index hydrophobic liquids and transmittance restoration agents for liquid lens formulations | 康宁股份有限公司 | 2020-11-06 | — | — | CN | claimed |
| US-9469604-B2 | Method of manufacturing sulfonium salt | TOYO GOSEI CO., LTD. (JP) | 2016-10-18 | — | — | US | claimed |
| CN-116657163-A | Method for dithioating o-dihalogenated aromatic hydrocarbon | 河南大学 | 2023-08-29 | — | — | CN | disclosed |
| US-11204492-B2 | Naphtyl based high index hydrophobic liquids and transmission recovery agents for liquid lens formulations | CORNING INCORPORATED (US) | 2021-12-21 | — | — | US | disclosed |
| CN-109293538-B | Preparation method of aryl sulfone compound, catalyst used for extraction and extraction method of aryl sulfone compound | 温州大学 | 2020-12-08 | — | — | CN | disclosed |
| US-20200142180-A1 | NAPHTYL BASED HIGH INDEX HYDROPHOBIC LIQUIDS AND TRANSMISSION RECOVERY AGENTS FOR LIQUID LENS FORMULATIONS | CORNING INC (US) | 2020-05-07 | — | — | US | disclosed |
| US-10558031-B2 | Naphtyl based high index hydrophobic liquids and transmission recovery agents for liquid lens formulations | CORNING INCORPORATED (US) | 2020-02-11 | — | — | US | disclosed |
| US-20190293920-A1 | NAPHTYL BASED HIGH INDEX HYDROPHOBIC LIQUIDS AND TRANSMISSION RECOVERY AGENTS FOR LIQUID LENS FORMULATIONS | CORNING INC (US) | 2019-09-26 | — | — | US | disclosed |
| US-10295819-B1 | Naphtyl based high index hydrophobic liquids and transmission recovery agents for liquid lens formulations | CORNING INCORPORATED (US) | 2019-05-21 | — | — | US | disclosed |
| WO-2018038464-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | 주식회사 두산 | 2018-03-01 | — | — | WO | disclosed |
| EP-3168207-A1 | MONOMER, POLYMER, RESIST COMPOSITION, AND PATTERNING PROCESS | Shin-Etsu Chemical Co., Ltd. (JP) | 2017-05-17 | — | — | EP | disclosed |
| EP-1350789-B1 | PROCESS FOR PRODUCING SULFONIUM SALT | SAN APRO LTD (JP) | 2008-06-25 | — | — | EP | disclosed |
| US-20080108720-A1 | Method for manufacturing monosulfonium salt, cationic polymerization initiator, curable composition, and cured product | DATE MASASHI | 2008-05-08 | — | — | US | disclosed |
| EP-1640363-B1 | PROCESS FOR PRODUCTION OF MONOSULFONIUM SALTS, CATIONIC POLYMERIZATION INITIATORS, CURABLE COMPOSITIONS, AND PRODUCTS OF CURING | SAN APRO LTD (JP) | 2008-01-16 | — | — | EP | disclosed |
| US-20060247401-A1 | Process for production of monosulfonium salts, cationic polymerization initiators, curable compositions, and products of curing | SAN-APRO LIMITED (JP) | 2006-11-02 | — | — | US | disclosed |
| US-7060858-B2 | Method for manufacturing sulfonium salts | SAN-APRO LIMITED (JP) | 2006-06-13 | — | — | US | disclosed |
| EP-1640363-A1 | PROCESS FOR PRODUCTION OF MONOSULFONIUM SALTS, CATIONIC POLYMERIZATION INITIATORS, CURABLE COMPOSITIONS, AND PRODUCTS OF CURING | San-Apro Limited (JP) | 2006-03-29 | — | — | EP | disclosed |
| US-20040030158-A1 | Method for manufacturing sulfonium salts | SAN-APRO LIMITED (JP) | 2004-02-12 | — | — | US | disclosed |
| EP-1350789-A1 | PROCESS FOR PRODUCING SULFONIUM SALT | San-Apro Limited (JP) | 2003-10-08 | — | — | EP | disclosed |
| US-4044056-A | Symmetrical aromatic sulfide production | PHILLIPS PETROLEUM COMPANY (US) | 1977-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060247401-A1 | Process for production of monosulfonium salts, cationic polymerization initiators, curable compositions, and products of curing | RPS6, SPIN4, SRM | LMNA 4180/4885SMN1; SMN2 1345/4885MAOA 3278/4885 |
| US-20040030158-A1 | Method for manufacturing sulfonium salts | MLX, STS, SULT1A1 | LMNA 4171/4885SMN1; SMN2 113/4885MAOA 831/4885 |
| US-20080108720-A1 | Method for manufacturing monosulfonium salt, cationic polymerization initiator, curable composition, and cured product | SPIN4, RPS6, SRM | LMNA 3894/4885SMN1; SMN2 978/4885MAOA 3349/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.